• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双侧卵巢癌:单中心起源的细胞遗传学证据。

Bilateral ovarian carcinoma: cytogenetic evidence of unicentric origin.

作者信息

Pejovic T, Heim S, Mandahl N, Elmfors B, Furgyik S, Flodérus U M, Helm G, Willén H, Mitelman F

机构信息

Department of Clinical Genetics, Lund University Hospital, Sweden.

出版信息

Int J Cancer. 1991 Feb 1;47(3):358-61. doi: 10.1002/ijc.2910470308.

DOI:10.1002/ijc.2910470308
PMID:1993543
Abstract

Cytogenetic analyses were performed on the tumors from both ovaries in 15 patients with bilateral ovarian carcinoma. In 4 of them, omental implants were also examined. Abnormal karyotypes were detected in 11 cases. The baseline karyotypes in the 2 tumorous ovaries were identical in each patient, indicating that bilateral ovarian cancer develops by metastatic spreading. There was no clear-cut evidence of differences in the clonal evolution between the tumors of the 2 ovaries, and hence the side harboring the primary tumor could never be determined. The metastatic nature of the omental implants was proved by the fact that their karyotypes were indistinguishable from those of the ovarian tumor tissue.

摘要

对15例双侧卵巢癌患者双侧卵巢的肿瘤进行了细胞遗传学分析。其中4例还检查了大网膜种植灶。11例检测到异常核型。每位患者双侧肿瘤性卵巢的基线核型相同,表明双侧卵巢癌是通过转移扩散发展而来。没有明确证据表明双侧卵巢肿瘤的克隆进化存在差异,因此无法确定原发肿瘤所在侧。大网膜种植灶的核型与卵巢肿瘤组织的核型无法区分,这证明了其转移性质。

相似文献

1
Bilateral ovarian carcinoma: cytogenetic evidence of unicentric origin.双侧卵巢癌:单中心起源的细胞遗传学证据。
Int J Cancer. 1991 Feb 1;47(3):358-61. doi: 10.1002/ijc.2910470308.
2
Karyotypic analysis of 32 malignant epithelial ovarian tumors.32例卵巢恶性上皮性肿瘤的核型分析
Cancer Genet Cytogenet. 1997 Jul 15;96(2):166-73. doi: 10.1016/s0165-4608(96)00327-5.
3
Chromosome aberrations in nine patients with ovarian cancer.9例卵巢癌患者的染色体畸变
Cancer Genet Cytogenet. 1989 Nov;43(1):1-14. doi: 10.1016/0165-4608(89)90122-2.
4
[Chromosome anomalies in 2 cases of human ovarian cancer].
C R Acad Sci III. 1986;302(3):81-6.
5
Chromosome aberrations in metastatic ovarian cancer: relationship with abnormalities in primary tumors.
Int J Cancer. 1990 Jan 15;45(1):50-4. doi: 10.1002/ijc.2910450111.
6
Consistent occurrence of a 19p+ marker chromosome and loss of 11p material in ovarian seropapillary cystadenocarcinomas.卵巢浆液性乳头状囊腺癌中19号染色体短臂增加标记染色体及11号染色体短臂物质缺失的一致性出现。
Genes Chromosomes Cancer. 1989 Nov;1(2):167-71. doi: 10.1002/gcc.2870010210.
7
Abnormal chromosomes including small metacentrics in 14 ovarian cancers.14例卵巢癌中存在包括小中着丝粒染色体在内的异常染色体。
Cancer Genet Cytogenet. 1987 Jun;26(2):355-61. doi: 10.1016/0165-4608(87)90070-7.
8
Cytogenetic observations on two ovarian carcinomas with double minutes, one with a 6q- marker chromosome.对两例伴有双微体的卵巢癌进行细胞遗传学观察,其中一例伴有一条6号染色体长臂缺失的标记染色体。
Cytobios. 1985;42(165):15-24.
9
Involvement of chromosome 6 in endometrial cancer.6号染色体与子宫内膜癌的关系。
Br J Cancer. 1997;75(12):1831-5. doi: 10.1038/bjc.1997.312.
10
Recurrent cytogenetic aberrations in human ovarian carcinomas.人类卵巢癌中的复发性细胞遗传学异常。
Cancer Detect Prev. 1995;19(3):234-43.

引用本文的文献

1
Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present.进化视角、异质性与卵巢癌:从过去到现在的复杂故事。
J Ovarian Res. 2022 Jun 3;15(1):67. doi: 10.1186/s13048-022-01004-1.
2
Profile of Chromosomal Alterations, Chromosomal Instability and Clonal Heterogeneity in Colombian Farmers Exposed to Pesticides.接触农药的哥伦比亚农民的染色体改变、染色体不稳定性和克隆异质性概况
Front Genet. 2022 Feb 24;13:820209. doi: 10.3389/fgene.2022.820209. eCollection 2022.
3
A rare and distinct bilateral ovarian tumor: Carcinosarcoma.
一种罕见且独特的双侧卵巢肿瘤:癌肉瘤。
Clin Case Rep. 2021 Dec 4;9(12):e05160. doi: 10.1002/ccr3.5160. eCollection 2021 Dec.
4
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors.原发性、转移性和复发性卵巢癌的突变全景揭示了 c-MYC 增益作为 BET 抑制剂的潜在靶标。
Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):619-624. doi: 10.1073/pnas.1814027116. Epub 2018 Dec 24.
5
Potential for Mitochondrial DNA Sequencing in the Differential Diagnosis of Gynaecological Malignancies.线粒体 DNA 测序在妇科恶性肿瘤鉴别诊断中的应用潜力。
Int J Mol Sci. 2018 Jul 13;19(7):2048. doi: 10.3390/ijms19072048.
6
Histopathological Pattern and Age Distribution, of Malignant Ovarian Tumor among Sudanese Ladies.苏丹女性恶性卵巢肿瘤的组织病理学模式与年龄分布
Open Access Maced J Med Sci. 2018 Feb 12;6(2):237-241. doi: 10.3889/oamjms.2018.067. eCollection 2018 Feb 15.
7
Bilateral ovarian carcinomas differ in the expression of metastasis-related genes.双侧卵巢癌在转移相关基因的表达上存在差异。
Oncol Lett. 2017 Jan;13(1):184-190. doi: 10.3892/ol.2016.5384. Epub 2016 Nov 14.
8
New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination.血源性卵巢癌转移的新模型显示其优先扩散至卵巢,且在腹腔播散过程中对卵巢有依赖性。
Transl Res. 2016 Sep;175:92-102.e2. doi: 10.1016/j.trsl.2016.03.016. Epub 2016 Mar 30.
9
Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours.对良性、低恶性潜能和低级别卵巢浆液性肿瘤进行全基因组 SNP 分析,研究染色体 3 异常。
PLoS One. 2011;6(12):e28250. doi: 10.1371/journal.pone.0028250. Epub 2011 Dec 6.
10
Tumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution.双侧卵巢癌中肿瘤转移至对侧卵巢是克隆进化中的晚期事件。
J Oncol. 2010;2010:646340. doi: 10.1155/2010/646340. Epub 2009 Sep 15.